Hepatic C-X-C chemokine receptor type 6–expressing innate lymphocytes limit detrimental myeloid hyperactivation in acute liver injury

View Publication
Abstract:
No abstract specified

SEEK ID: https://seek.lisym.org/publications/379

DOI: 10.1097/HC9.0000000000000102

Projects: DEEP-HCC network, Forschungsnetzwerk LiSyM-Krebs

Publication type: Journal

Journal: Hepatology Communications

Citation: Hepatology Communications 7(4)

Date Published: 2023

Registered Mode: by DOI

Authors: Felix Heymann, Jana C. Mossanen, Moritz Peiseler, Patricia M. Niemietz, Bruna Araujo David, Oliver Krenkel, Anke Liepelt, Matheus Batista Carneiro, Marlene S. Kohlhepp, Paul Kubes, Frank Tacke

help Submitter
Citation
Heymann, F., Mossanen, J. C., Peiseler, M., Niemietz, P. M., Araujo David, B., Krenkel, O., Liepelt, A., Batista Carneiro, M., Kohlhepp, M. S., Kubes, P., & Tacke, F. (2023). Hepatic C-X-C chemokine receptor type 6–expressing innate lymphocytes limit detrimental myeloid hyperactivation in acute liver injury. In Hepatology Communications (Vol. 7, Issue 4). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/hc9.0000000000000102
Activity

Views: 365

Created: 10th Aug 2023 at 09:48

Last updated: 8th Mar 2024 at 07:44

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
 (v.1.14.2)
About FAIRDOM | About LiSyM | Funding and Programmes | Credits | Terms & Conditions | Imprint
Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH